Concerns regarding the safety and efficacy of ES-Cu-Captisol for Menkes disease. Reply.
Por:
Gohil, VM, Petris, MJ and Palau F
Publicada:
16 feb 2026
Resumen:
Filiaciones:
Gohil, VM:
Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX USA
Petris, MJ:
Univ Missouri, Dept Ophthalmol & Biochem, Columbia, MO USA
Palau F:
Univ Barcelona, St Joan Deu Hosp & Res Inst, Ctr Genom Sci Med, Barcelona, Spain
Univ Barcelona, CIBERER, Barcelona, Spain
Green Submitted, gold
|